B-type natriuretic peptide as a predictor of anterior wall location in patients with non-ST-elevation myocardial

Rogério Bicudo Ramos1, Célia M Strunz, Solange Desirée Avakian

  • 1Heart Institute, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

Insights

B-type natriuretic peptide levels are key predictors of anterior wall myocardial infarction in non-ST-elevation myocardial infarction patients. Higher peptide levels also indicate increased risk for cardiac events during hospitalization and follow-up.

Area of Science:

  • Cardiology
  • Biomarkers in Cardiovascular Disease
  • Myocardial Infarction Research

Background:

  • Anterior wall involvement in ST-elevation myocardial infarction is linked to poorer prognosis.
  • Noninvasive methods for identifying ischemic territories in non-ST-elevation myocardial infarction are limited.

Purpose of the Study:

  • To identify predictive factors for anterior myocardial territory location in non-ST-elevation myocardial infarction.
  • To investigate the association between B-type natriuretic peptide and anterior wall infarcts.

Main Methods:

  • Analysis of clinical, echocardiographic, and laboratory data from 170 non-ST-elevation myocardial infarction patients.
  • Measurement of B-type natriuretic peptide within 24 hours of hospitalization.
  • Coronary angiographic assessment of infarct territory.

Main Results:

  • B-type natriuretic peptide was the sole independent predictor of anterior wall infarct in non-ST-elevation myocardial infarction (OR = 3.70).
  • Elevated B-type natriuretic peptide predicted in-hospital cardiac events (OR = 5.05) and follow-up cardiac events (HR = 1.79).
  • 47% of patients had anterior wall involvement, while 53% had inferior and lateral involvement.

Conclusions:

  • B-type natriuretic peptide is the only independent factor associated with anterior wall involvement in non-ST-elevation myocardial infarction.
  • Admission B-type natriuretic peptide levels predict both in-hospital and subsequent cardiac events.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...